healthcare-medical

Global Custom Market Research Reports Provider Company

phone

Immunovaccine Inc (IMV) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: Canada
Summary

Immunovaccine Inc (IMV), formerly Rhino Resources Inc is a clinical-stage immuno-oncology company that develops cancer immunotherapies and infectious disease vaccines. The company develops its products based on DepoVax platform, a vaccine adjuvant and delivery platform technology. Its immuno oncology pipeline products are intended for the treatment of ovarian, diffuse large B cell lymphoma (DLBCL) tumors and human papillomavirus (HPV) cervical cancer. IMVs infectious disease product candidates are intended for the treatment of respiratory syncytial virus, malaria and others. The company partners with various universities, research institutes and other vaccine development companies to develop its product candidates for applications in cancer and infectious diseases. IMV is headquartered in Halifax, Nova Scotia, Canada.

Immunovaccine Inc Key Recent Developments

Jan 31,2018: Published Study Demonstrates the Association Between Immunovaccines Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression
Jan 18,2018: Immunovaccine Appoints Joseph Sullivan as Senior Vice President of Business Development
Nov 09,2017: Immunovaccine Announces Third Quarter 2017 Financial Results
Oct 17,2017: Immunovaccine Receives an Extension to the Maturity Date of its $5M Loan Until 2020
Aug 08,2017: Immunovaccine Announces Financial Results for Quarter Ended June 30, 2017

This comprehensive SWOT profile of Immunovaccine Inc provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunovaccine Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData


Section 1 - About the Company

Immunovaccine Inc - Key Information
Immunovaccine Inc - Overview
Immunovaccine Inc - Key Employees
Immunovaccine Inc - Key Employee Biographies
Immunovaccine Inc - Key Operational Heads
Immunovaccine Inc - Major Products and Services
Immunovaccine Inc - History
Immunovaccine Inc - Company Statement
Immunovaccine Inc - Locations And Subsidiaries
Immunovaccine Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Immunovaccine Inc - Business Description
Immunovaccine Inc - Corporate Strategy
Immunovaccine Inc - SWOT Analysis
SWOT Analysis - Overview
Immunovaccine Inc - Strengths
Immunovaccine Inc - Weaknesses
Immunovaccine Inc - Opportunities
Immunovaccine Inc - Threats
Immunovaccine Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Immunovaccine Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

Immunovaccine Inc, Key Information
Immunovaccine Inc, Key Ratios
Immunovaccine Inc, Share Data
Immunovaccine Inc, Major Products and Services
Immunovaccine Inc, History
Immunovaccine Inc, Key Employees
Immunovaccine Inc, Key Employee Biographies
Immunovaccine Inc, Key Operational Heads
Immunovaccine Inc, Other Locations
Immunovaccine Inc, Subsidiaries
Immunovaccine Inc, Key Manufacturing facilities
Immunovaccine Inc, Key Competitors
Immunovaccine Inc, SWOT Analysis
Immunovaccine Inc, Ratios based on current share price
Immunovaccine Inc, Annual Ratios
Immunovaccine Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

Immunovaccine Inc, Performance Chart
Immunovaccine Inc, Ratio Charts

Immunovaccine Inc (IMV), formerly Rhino Resources Inc is a clinical-stage immuno-oncology company that develops cancer immunotherapies and infectious disease vaccines. The company develops its products based on DepoVax platform, a

View Report

Immunovaccine Inc (IMV), formerly Rhino Resources Inc is a clinical-stage immuno-oncology company that develops cancer immunotherapies and infectious disease vaccines. The company develops its products based on DepoVax platform, a

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports